Neurotrials Research Inc Listed as Ransomware Victim on Dark Web by SINOBI Threat Actors

Clinical research organization Neurotrials Research Inc has been identified as the latest victim in a ransomware campaign, with the breach disclosed through dark web channels monitored by threat intelligence sources. The organization, which conducts neurological and clinical trials, now faces potential exposure of sensitive research data and participant information as threat actors move to publicize the incident.

The ransomware group SINOBI has claimed responsibility for the attack, listing Neurotrials Research Inc among its victims on dark web infrastructure. The disclosure was surfaced through open-source intelligence monitoring and verified by Red Packet Security, which tracks ransomware activity and data breach incidents. While specific details regarding the scope of compromised data, ransom demands, or attack vectors have not yet been publicly disclosed, the listing itself signals that the threat actors intend to pressure the organization through public exposure—a common tactic in modern ransomware operations.

The targeting of a clinical research firm raises particular concerns given the nature of data typically held by such organizations, including patient health information, trial protocols, and proprietary research materials. Ransomware attacks against healthcare and research entities have intensified in recent years, as attackers calculate that these organizations face higher pressure to resolve incidents quickly. The full impact on Neurotrials Research Inc, its partners, and any individuals whose data may have been accessed remains unclear pending further investigation or disclosure from the company. Security researchers and OSINT analysts continue to monitor the situation for additional leaked materials or statements from the threat actors.